Therapeutic Plasma Exchange Systems Market Size, Share, Industry Trends and Forecast to 2030

Therapeutic Plasma Exchange Systems Market Size & CAGR in 2021

The global therapeutic plasma exchange systems market is expected to have a growth rate of 5.17% CAGR from 2021 to 2030. As a result, the market is anticipated to grow significantly by 2028.

COVID-19 Impact on the Therapeutic Plasma Exchange Systems Market

The COVID-19 pandemic has had a significant impact on the therapeutic plasma exchange systems market. With healthcare systems overwhelmed and focus shifted to treating COVID-19 patients, the demand for therapeutic plasma exchange systems saw a slight decline initially. However, as the understanding of the virus increased, the use of therapeutic plasma exchange systems in severe COVID-19 cases became more common, leading to a resurgence in demand.

Therapeutic Plasma Exchange Systems Dynamics

Therapeutic plasma exchange systems are medical devices used to treat various autoimmune diseases, neurological disorders, and toxicological emergencies by removing harmful substances from the plasma. The market for these systems is driven by factors such as the increasing prevalence of autoimmune diseases, advancements in technology, and growing awareness about the benefits of therapeutic plasma exchange.

Segments and Related Analysis

The therapeutic plasma exchange systems market can be segmented based on product type, application, end-user, and region. Common product types include disposable kits, machines, and accessories. Applications of therapeutic plasma exchange systems include neurological disorders, autoimmune diseases, and toxicological emergencies. End-users of these systems include hospitals, clinics, and ambulatory surgical centers.

By Region Analysis

Regionally, North America is expected to dominate the therapeutic plasma exchange systems market, followed by Europe and Asia Pacific. The presence of well-established healthcare infrastructure, increasing prevalence of autoimmune diseases, and significant investments in research and development are some of the factors driving the market growth in these regions.

Key Market Players and Competitive Landscape

Some of the key players in the therapeutic plasma exchange systems market include Fresenius SE & Co. KGaA, Kawasumi Laboratories, Inc., Terumo Corporation, Haemonetics Corporation, B. Braun Melsungen AG, and Therakos, Inc. These companies are focusing on product development, strategic partnerships, and acquisitions to gain a competitive edge in the market.

Recent Happenings in the Therapeutic Plasma Exchange Systems Market

- In April 2022, Terumo Corporation announced the launch of a new therapeutic plasma exchange system with advanced features for improved patient care.

- In May 2021, Fresenius SE & Co. KGaA entered into a strategic partnership with a leading research institute to develop innovative therapeutic plasma exchange technologies.

- In September 2020, Haemonetics Corporation introduced a new generation of therapeutic plasma exchange machines designed to enhance treatment efficacy and patient comfort.